^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    anti-LeY- scFv-CD28-ζ vector

    i
    Associations
    News
    Trials
    Company:
    BMS, Peter MacCallum Cancer Centre
    Drug class:
    Lewis Y antigen-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials